This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-106a-5p | ABCA1 | 2.49 | 0 | -0.71 | 0.00276 | MirTarget; miRNATAP | -0.12 | 7.0E-5 | NA | |
2 | hsa-miR-106b-5p | ABCA1 | 2.47 | 0 | -0.71 | 0.00276 | MirTarget; miRNATAP | -0.21 | 0 | NA | |
3 | hsa-miR-93-5p | ABCA1 | 3.04 | 0 | -0.71 | 0.00276 | MirTarget; miRNATAP | -0.21 | 0 | NA | |
4 | hsa-miR-106a-5p | ABCD2 | 2.49 | 0 | -3.08 | 0 | MirTarget | -0.35 | 0 | NA | |
5 | hsa-miR-106b-5p | ABCD2 | 2.47 | 0 | -3.08 | 0 | MirTarget | -0.8 | 0 | NA | |
6 | hsa-miR-93-5p | ABCD2 | 3.04 | 0 | -3.08 | 0 | MirTarget | -0.74 | 0 | NA | |
7 | hsa-miR-106b-5p | ABHD2 | 2.47 | 0 | -0.37 | 0.12248 | miRNATAP | -0.13 | 0.00297 | NA | |
8 | hsa-miR-106b-5p | ABL2 | 2.47 | 0 | -0.32 | 0.04554 | MirTarget | -0.13 | 1.0E-5 | NA | |
9 | hsa-miR-93-5p | ABL2 | 3.04 | 0 | -0.32 | 0.04554 | MirTarget | -0.14 | 0 | NA | |
10 | hsa-miR-20a-3p | ABLIM1 | 2.93 | 0 | -1.72 | 0 | mirMAP | -0.12 | 0.00179 | NA | |
11 | hsa-miR-106a-5p | ADAM19 | 2.49 | 0 | -1.06 | 0.01895 | mirMAP | -0.33 | 0 | NA | |
12 | hsa-miR-106b-5p | ADAM19 | 2.47 | 0 | -1.06 | 0.01895 | mirMAP | -0.7 | 0 | NA | |
13 | hsa-miR-93-5p | ADAM19 | 3.04 | 0 | -1.06 | 0.01895 | mirMAP | -0.62 | 0 | NA | |
14 | hsa-miR-106b-5p | ADAM9 | 2.47 | 0 | -0.2 | 0.40665 | miRNATAP | -0.3 | 0 | NA | |
15 | hsa-miR-93-5p | ADAM9 | 3.04 | 0 | -0.2 | 0.40665 | miRNATAP | -0.22 | 0 | NA | |
16 | hsa-miR-106b-5p | ADAMTS5 | 2.47 | 0 | -2.16 | 0 | miRNATAP | -0.52 | 0 | NA | |
17 | hsa-miR-20a-3p | ADAMTS6 | 2.93 | 0 | -0.88 | 0.01914 | miRNATAP | -0.25 | 0 | NA | |
18 | hsa-miR-106a-5p | ADARB1 | 2.49 | 0 | -1.93 | 0 | MirTarget | -0.28 | 0 | NA | |
19 | hsa-miR-106b-5p | ADARB1 | 2.47 | 0 | -1.93 | 0 | MirTarget | -0.54 | 0 | NA | |
20 | hsa-miR-20a-3p | ADARB1 | 2.93 | 0 | -1.93 | 0 | mirMAP | -0.29 | 0 | NA | |
21 | hsa-miR-93-5p | ADARB1 | 3.04 | 0 | -1.93 | 0 | miRNAWalker2 validate; MirTarget | -0.44 | 0 | NA | |
22 | hsa-miR-106a-5p | ADCY9 | 2.49 | 0 | -1.5 | 0 | mirMAP | -0.21 | 0 | NA | |
23 | hsa-miR-106b-5p | ADCY9 | 2.47 | 0 | -1.5 | 0 | mirMAP | -0.51 | 0 | NA | |
24 | hsa-miR-93-5p | ADCY9 | 3.04 | 0 | -1.5 | 0 | mirMAP | -0.42 | 0 | NA | |
25 | hsa-miR-106b-5p | ADRA2A | 2.47 | 0 | -2.58 | 0 | miRNATAP | -0.65 | 0 | NA | |
26 | hsa-miR-20a-3p | AFF2 | 2.93 | 0 | -1.73 | 0.00201 | mirMAP | -0.28 | 0.00032 | NA | |
27 | hsa-miR-106b-5p | AFF4 | 2.47 | 0 | -0.82 | 0 | miRNATAP | -0.11 | 0.00011 | NA | |
28 | hsa-miR-93-5p | AFF4 | 3.04 | 0 | -0.82 | 0 | miRNATAP | -0.12 | 0 | NA | |
29 | hsa-miR-106b-5p | AGFG1 | 2.47 | 0 | -0.17 | 0.30925 | MirTarget | -0.15 | 0 | NA | |
30 | hsa-miR-93-5p | AGFG1 | 3.04 | 0 | -0.17 | 0.30925 | MirTarget | -0.14 | 0 | NA | |
31 | hsa-miR-20a-3p | AGFG2 | 2.93 | 0 | -0.51 | 0.00539 | mirMAP | -0.13 | 0 | NA | |
32 | hsa-miR-106a-5p | AHNAK | 2.49 | 0 | -1.66 | 0 | miRNATAP | -0.31 | 0 | NA | |
33 | hsa-miR-106b-5p | AHNAK | 2.47 | 0 | -1.66 | 0 | miRNATAP | -0.55 | 0 | NA | |
34 | hsa-miR-93-5p | AHNAK | 3.04 | 0 | -1.66 | 0 | miRNATAP | -0.47 | 0 | NA | |
35 | hsa-miR-106b-5p | AKAP11 | 2.47 | 0 | -0.8 | 0 | miRNAWalker2 validate | -0.18 | 0 | NA | |
36 | hsa-miR-20a-3p | AKAP11 | 2.93 | 0 | -0.8 | 0 | MirTarget; miRNATAP | -0.11 | 0 | NA | |
37 | hsa-miR-93-5p | AKAP11 | 3.04 | 0 | -0.8 | 0 | miRNAWalker2 validate | -0.16 | 0 | NA | |
38 | hsa-miR-106a-5p | AKAP13 | 2.49 | 0 | -1.15 | 0 | MirTarget; mirMAP; miRNATAP | -0.17 | 0 | NA | |
39 | hsa-miR-106b-5p | AKAP13 | 2.47 | 0 | -1.15 | 0 | MirTarget; mirMAP; miRNATAP | -0.34 | 0 | NA | |
40 | hsa-miR-93-5p | AKAP13 | 3.04 | 0 | -1.15 | 0 | MirTarget; miRNATAP | -0.29 | 0 | NA | |
41 | hsa-miR-20a-3p | AKAP6 | 2.93 | 0 | -3.34 | 0 | MirTarget | -0.59 | 0 | NA | |
42 | hsa-miR-106a-5p | AKT3 | 2.49 | 0 | -1.94 | 0 | miRNATAP | -0.24 | 0 | NA | |
43 | hsa-miR-106b-5p | AKT3 | 2.47 | 0 | -1.94 | 0 | miRNATAP | -0.52 | 0 | NA | |
44 | hsa-miR-93-5p | AKT3 | 3.04 | 0 | -1.94 | 0 | miRNATAP | -0.49 | 0 | NA | |
45 | hsa-miR-93-5p | ALDH1A3 | 3.04 | 0 | -1.34 | 0.0022 | mirMAP | -0.39 | 0 | NA | |
46 | hsa-miR-106b-5p | ALDH3A2 | 2.47 | 0 | -0.63 | 0.00987 | mirMAP | -0.16 | 0.00048 | NA | |
47 | hsa-miR-106a-5p | ALPK3 | 2.49 | 0 | -1.02 | 0.00049 | mirMAP | -0.13 | 0.00095 | NA | |
48 | hsa-miR-106b-5p | ALPK3 | 2.47 | 0 | -1.02 | 0.00049 | mirMAP | -0.3 | 0 | NA | |
49 | hsa-miR-20a-3p | ANGPTL1 | 2.93 | 0 | -4.51 | 0 | MirTarget | -0.9 | 0 | NA | |
50 | hsa-miR-106a-5p | ANK2 | 2.49 | 0 | -4.32 | 0 | MirTarget; miRNATAP | -0.38 | 0 | NA | |
51 | hsa-miR-106b-5p | ANK2 | 2.47 | 0 | -4.32 | 0 | MirTarget; miRNATAP | -0.94 | 0 | NA | |
52 | hsa-miR-93-5p | ANK2 | 3.04 | 0 | -4.32 | 0 | MirTarget; miRNATAP | -0.82 | 0 | NA | |
53 | hsa-miR-106a-5p | ANKH | 2.49 | 0 | -0.38 | 0.21654 | MirTarget | -0.17 | 4.0E-5 | NA | |
54 | hsa-miR-106b-5p | ANKH | 2.47 | 0 | -0.38 | 0.21654 | MirTarget | -0.43 | 0 | NA | |
55 | hsa-miR-93-5p | ANKH | 3.04 | 0 | -0.38 | 0.21654 | MirTarget | -0.32 | 0 | NA | |
56 | hsa-miR-106a-5p | ANKRD29 | 2.49 | 0 | -3.47 | 0 | MirTarget | -0.51 | 0 | NA | |
57 | hsa-miR-106b-5p | ANKRD29 | 2.47 | 0 | -3.47 | 0 | MirTarget | -1.13 | 0 | NA | |
58 | hsa-miR-93-5p | ANKRD29 | 3.04 | 0 | -3.47 | 0 | miRNAWalker2 validate; MirTarget | -0.9 | 0 | NA | |
59 | hsa-miR-106a-5p | ANKRD50 | 2.49 | 0 | -0.88 | 0.00174 | MirTarget; miRNATAP | -0.11 | 0.0047 | NA | |
60 | hsa-miR-106b-5p | ANKRD50 | 2.47 | 0 | -0.88 | 0.00174 | MirTarget; miRNATAP | -0.2 | 0.00016 | NA | |
61 | hsa-miR-20a-3p | ANKRD50 | 2.93 | 0 | -0.88 | 0.00174 | MirTarget; miRNATAP | -0.13 | 0.00061 | NA | |
62 | hsa-miR-93-5p | ANKRD50 | 3.04 | 0 | -0.88 | 0.00174 | MirTarget; miRNATAP | -0.15 | 0.00071 | NA | |
63 | hsa-miR-106b-5p | ANO6 | 2.47 | 0 | -0.74 | 3.0E-5 | MirTarget | -0.13 | 0.00012 | NA | |
64 | hsa-miR-93-5p | ANO6 | 3.04 | 0 | -0.74 | 3.0E-5 | MirTarget; miRNATAP | -0.11 | 3.0E-5 | NA | |
65 | hsa-miR-106a-5p | ANXA11 | 2.49 | 0 | -0.43 | 0.01849 | mirMAP | -0.12 | 0 | NA | |
66 | hsa-miR-106b-5p | ANXA11 | 2.47 | 0 | -0.43 | 0.01849 | mirMAP | -0.15 | 0 | NA | |
67 | hsa-miR-20a-3p | ANXA11 | 2.93 | 0 | -0.43 | 0.01849 | mirMAP | -0.1 | 5.0E-5 | NA | |
68 | hsa-miR-106a-5p | APBB2 | 2.49 | 0 | -0.59 | 0.0014 | MirTarget; miRNATAP | -0.15 | 0 | NA | |
69 | hsa-miR-106b-5p | APBB2 | 2.47 | 0 | -0.59 | 0.0014 | MirTarget; miRNATAP | -0.3 | 0 | NA | |
70 | hsa-miR-93-5p | APBB2 | 3.04 | 0 | -0.59 | 0.0014 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.26 | 0 | NA | |
71 | hsa-miR-106b-5p | APCDD1 | 2.47 | 0 | -1.6 | 0 | MirTarget | -0.17 | 0.00845 | NA | |
72 | hsa-miR-93-5p | APCDD1 | 3.04 | 0 | -1.6 | 0 | MirTarget | -0.16 | 0.0035 | NA | |
73 | hsa-miR-106a-5p | APP | 2.49 | 0 | -0.4 | 0.04288 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.14 | 0 | NA | |
74 | hsa-miR-106b-5p | APP | 2.47 | 0 | -0.4 | 0.04288 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.26 | 0 | NA | |
75 | hsa-miR-93-5p | APP | 3.04 | 0 | -0.4 | 0.04288 | miRNATAP | -0.22 | 0 | NA | |
76 | hsa-miR-106a-5p | ARHGAP1 | 2.49 | 0 | -0.88 | 0 | MirTarget; miRNATAP | -0.17 | 0 | NA | |
77 | hsa-miR-106b-5p | ARHGAP1 | 2.47 | 0 | -0.88 | 0 | MirTarget; miRNATAP | -0.36 | 0 | NA | |
78 | hsa-miR-93-5p | ARHGAP1 | 3.04 | 0 | -0.88 | 0 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.26 | 0 | NA | |
79 | hsa-miR-106a-5p | ARHGAP24 | 2.49 | 0 | -2.02 | 0 | MirTarget | -0.33 | 0 | NA | |
80 | hsa-miR-106b-5p | ARHGAP24 | 2.47 | 0 | -2.02 | 0 | MirTarget | -0.67 | 0 | NA | |
81 | hsa-miR-93-5p | ARHGAP24 | 3.04 | 0 | -2.02 | 0 | MirTarget | -0.55 | 0 | NA | |
82 | hsa-miR-106b-5p | ARHGAP26 | 2.47 | 0 | -0.72 | 0.00357 | MirTarget; mirMAP; miRNATAP | -0.15 | 0.00134 | NA | |
83 | hsa-miR-93-5p | ARHGAP26 | 3.04 | 0 | -0.72 | 0.00357 | MirTarget; mirMAP; miRNATAP | -0.12 | 0.0011 | NA | |
84 | hsa-miR-106a-5p | ARHGEF3 | 2.49 | 0 | -0.76 | 0 | MirTarget; miRNATAP | -0.12 | 0 | NA | |
85 | hsa-miR-106b-5p | ARHGEF3 | 2.47 | 0 | -0.76 | 0 | MirTarget; miRNATAP | -0.26 | 0 | NA | |
86 | hsa-miR-93-5p | ARHGEF3 | 3.04 | 0 | -0.76 | 0 | MirTarget; miRNATAP | -0.23 | 0 | NA | |
87 | hsa-miR-106a-5p | ARL10 | 2.49 | 0 | -1.12 | 0.00198 | mirMAP | -0.2 | 2.0E-5 | NA | |
88 | hsa-miR-106b-5p | ARL10 | 2.47 | 0 | -1.12 | 0.00198 | mirMAP | -0.29 | 2.0E-5 | NA | |
89 | hsa-miR-93-5p | ARL10 | 3.04 | 0 | -1.12 | 0.00198 | mirMAP | -0.3 | 0 | NA | |
90 | hsa-miR-106b-5p | ARL4A | 2.47 | 0 | -0.62 | 0.01525 | miRNATAP | -0.15 | 0.00212 | NA | |
91 | hsa-miR-106a-5p | ARL4C | 2.49 | 0 | -0.28 | 0.33535 | MirTarget; miRNATAP | -0.22 | 0 | NA | |
92 | hsa-miR-106b-5p | ARL4C | 2.47 | 0 | -0.28 | 0.33535 | MirTarget; miRNATAP | -0.39 | 0 | NA | |
93 | hsa-miR-93-5p | ARL4C | 3.04 | 0 | -0.28 | 0.33535 | MirTarget; miRNATAP | -0.3 | 0 | NA | |
94 | hsa-miR-106a-5p | ARSB | 2.49 | 0 | -0.58 | 0.00052 | mirMAP | -0.15 | 0 | NA | |
95 | hsa-miR-106b-5p | ARSB | 2.47 | 0 | -0.58 | 0.00052 | mirMAP | -0.31 | 0 | NA | |
96 | hsa-miR-93-5p | ARSJ | 3.04 | 0 | -1.58 | 0.00066 | miRNAWalker2 validate | -0.68 | 0 | NA | |
97 | hsa-miR-106b-5p | ASAP1 | 2.47 | 0 | 0.06 | 0.77944 | miRNAWalker2 validate | -0.1 | 0.00872 | NA | |
98 | hsa-miR-93-5p | ASB1 | 3.04 | 0 | -0.87 | 0 | miRNAWalker2 validate | -0.13 | 0 | NA | |
99 | hsa-miR-93-5p | ASH1L | 3.04 | 0 | -0.67 | 0.00016 | miRNATAP | -0.1 | 0.00015 | NA | |
100 | hsa-miR-106a-5p | ASPA | 2.49 | 0 | -4.76 | 0 | mirMAP | -0.26 | 0.001 | NA | |
101 | hsa-miR-106b-5p | ASPA | 2.47 | 0 | -4.76 | 0 | mirMAP | -0.68 | 0 | NA | |
102 | hsa-miR-20a-3p | ASPA | 2.93 | 0 | -4.76 | 0 | mirMAP | -0.59 | 0 | NA | |
103 | hsa-miR-93-5p | ASPA | 3.04 | 0 | -4.76 | 0 | mirMAP | -0.5 | 0 | NA | |
104 | hsa-miR-106a-5p | ATE1 | 2.49 | 0 | -1.09 | 3.0E-5 | MirTarget | -0.11 | 0.00166 | NA | |
105 | hsa-miR-106b-5p | ATE1 | 2.47 | 0 | -1.09 | 3.0E-5 | MirTarget | -0.15 | 0.00238 | NA | |
106 | hsa-miR-93-5p | ATE1 | 3.04 | 0 | -1.09 | 3.0E-5 | MirTarget | -0.19 | 0 | NA | |
107 | hsa-miR-106b-5p | ATG16L1 | 2.47 | 0 | -0.3 | 0.0152 | MirTarget; miRNATAP | -0.11 | 0 | NA | |
108 | hsa-miR-106b-5p | ATL3 | 2.47 | 0 | -0.19 | 0.4343 | MirTarget; miRNATAP | -0.24 | 0 | NA | |
109 | hsa-miR-93-5p | ATL3 | 3.04 | 0 | -0.19 | 0.4343 | MirTarget; miRNATAP | -0.2 | 0 | NA | |
110 | hsa-miR-106a-5p | ATP1A2 | 2.49 | 0 | -6.96 | 0 | MirTarget | -0.8 | 0 | NA | |
111 | hsa-miR-106b-5p | ATP1A2 | 2.47 | 0 | -6.96 | 0 | MirTarget; miRNATAP | -1.56 | 0 | NA | |
112 | hsa-miR-93-5p | ATP1A2 | 3.04 | 0 | -6.96 | 0 | MirTarget | -1.14 | 0 | NA | |
113 | hsa-miR-106b-5p | ATP2A2 | 2.47 | 0 | -0.4 | 0.01225 | mirMAP | -0.11 | 0.00016 | NA | |
114 | hsa-miR-20a-3p | ATP8A1 | 2.93 | 0 | -1.48 | 8.0E-5 | MirTarget | -0.18 | 0.00039 | NA | |
115 | hsa-miR-106a-5p | ATXN1 | 2.49 | 0 | -1.51 | 0 | miRNATAP | -0.28 | 0 | NA | |
116 | hsa-miR-106b-5p | ATXN1 | 2.47 | 0 | -1.51 | 0 | miRNATAP | -0.56 | 0 | NA | |
117 | hsa-miR-93-5p | ATXN1 | 3.04 | 0 | -1.51 | 0 | miRNAWalker2 validate; miRNATAP | -0.46 | 0 | NA | |
118 | hsa-miR-93-5p | ATXN1L | 3.04 | 0 | -0.47 | 0.0041 | miRNATAP | -0.1 | 6.0E-5 | NA | |
119 | hsa-miR-93-5p | B2M | 3.04 | 0 | -0 | 0.98848 | miRNAWalker2 validate | -0.23 | 0 | NA | |
120 | hsa-miR-106a-5p | B3GALT2 | 2.49 | 0 | -3.85 | 0 | MirTarget | -0.28 | 0 | NA | |
121 | hsa-miR-106b-5p | B3GALT2 | 2.47 | 0 | -3.85 | 0 | MirTarget | -0.57 | 0 | NA | |
122 | hsa-miR-93-5p | B3GALT2 | 3.04 | 0 | -3.85 | 0 | MirTarget | -0.52 | 0 | NA | |
123 | hsa-miR-106b-5p | BACH1 | 2.47 | 0 | -0.27 | 0.16316 | mirMAP | -0.15 | 2.0E-5 | NA | |
124 | hsa-miR-93-5p | BACH1 | 3.04 | 0 | -0.27 | 0.16316 | mirMAP | -0.17 | 0 | NA | |
125 | hsa-miR-93-5p | BAG2 | 3.04 | 0 | -2.37 | 0 | miRNAWalker2 validate | -0.55 | 0 | NA | |
126 | hsa-miR-106b-5p | BBX | 2.47 | 0 | -0.51 | 0.00131 | MirTarget; miRNATAP | -0.16 | 0 | NA | |
127 | hsa-miR-93-5p | BBX | 3.04 | 0 | -0.51 | 0.00131 | MirTarget; miRNATAP | -0.15 | 0 | NA | |
128 | hsa-miR-20a-3p | BCL2 | 2.93 | 0 | -2.02 | 0 | mirMAP | -0.21 | 0 | NA | |
129 | hsa-miR-106a-5p | BCL2L2 | 2.49 | 0 | -1.27 | 0 | miRNATAP | -0.1 | 1.0E-5 | NA | |
130 | hsa-miR-106b-5p | BCL2L2 | 2.47 | 0 | -1.27 | 0 | miRNATAP | -0.25 | 0 | NA | |
131 | hsa-miR-93-5p | BCL2L2 | 3.04 | 0 | -1.27 | 0 | miRNATAP | -0.2 | 0 | NA | |
132 | hsa-miR-106b-5p | BCL9L | 2.47 | 0 | -0.07 | 0.6694 | mirMAP | -0.2 | 0 | NA | |
133 | hsa-miR-93-5p | BEND4 | 3.04 | 0 | -1.97 | 7.0E-5 | mirMAP | -0.26 | 0.00074 | NA | |
134 | hsa-miR-106b-5p | BICD2 | 2.47 | 0 | -0.46 | 0.01378 | MirTarget; miRNATAP | -0.11 | 0.00092 | NA | |
135 | hsa-miR-93-5p | BICD2 | 3.04 | 0 | -0.46 | 0.01378 | MirTarget; miRNATAP | -0.11 | 0.00012 | NA | |
136 | hsa-miR-106a-5p | BMPR2 | 2.49 | 0 | -0.59 | 4.0E-5 | MirTarget; miRNATAP | -0.13 | 0 | NA | |
137 | hsa-miR-106b-5p | BMPR2 | 2.47 | 0 | -0.59 | 4.0E-5 | MirTarget; miRNATAP | -0.2 | 0 | NA | |
138 | hsa-miR-93-5p | BMPR2 | 3.04 | 0 | -0.59 | 4.0E-5 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.19 | 0 | NA | |
139 | hsa-miR-106a-5p | BNC2 | 2.49 | 0 | -2.95 | 0 | miRNATAP | -0.6 | 0 | NA | |
140 | hsa-miR-106b-5p | BNC2 | 2.47 | 0 | -2.95 | 0 | miRNATAP | -1.15 | 0 | NA | |
141 | hsa-miR-93-5p | BNC2 | 3.04 | 0 | -2.95 | 0 | miRNATAP | -0.94 | 0 | NA | |
142 | hsa-miR-106b-5p | BNIP3L | 2.47 | 0 | -0.6 | 0.00028 | MirTarget | -0.1 | 0.00077 | NA | |
143 | hsa-miR-106b-5p | BRMS1L | 2.47 | 0 | -0.51 | 0.00391 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.15 | 0 | NA | |
144 | hsa-miR-93-5p | BRMS1L | 3.04 | 0 | -0.51 | 0.00391 | MirTarget; miRNATAP | -0.13 | 0 | NA | |
145 | hsa-miR-106b-5p | BTG1 | 2.47 | 0 | -0.8 | 2.0E-5 | miRNATAP | -0.19 | 0 | NA | |
146 | hsa-miR-106b-5p | BTN3A3 | 2.47 | 0 | -0.13 | 0.6214 | miRNAWalker2 validate | -0.23 | 0 | NA | |
147 | hsa-miR-20a-3p | BVES | 2.93 | 0 | -2.76 | 0 | mirMAP | -0.35 | 0 | NA | |
148 | hsa-miR-20a-3p | C14orf132 | 2.93 | 0 | -1.97 | 0 | mirMAP | -0.32 | 0 | NA | |
149 | hsa-miR-106a-5p | C14orf28 | 2.49 | 0 | -0.89 | 0 | miRNATAP | -0.11 | 0 | NA | |
150 | hsa-miR-106b-5p | C14orf28 | 2.47 | 0 | -0.89 | 0 | miRNATAP | -0.19 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | REGULATION OF CELL DIFFERENTIATION | 124 | 1492 | 1.594e-17 | 7.416e-14 |
2 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 132 | 1672 | 8.063e-17 | 1.876e-13 |
3 | CELL DEVELOPMENT | 115 | 1426 | 2.56e-15 | 3.971e-12 |
4 | NEUROGENESIS | 112 | 1402 | 1.21e-14 | 9.381e-12 |
5 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 77 | 788 | 1.111e-14 | 9.381e-12 |
6 | CIRCULATORY SYSTEM DEVELOPMENT | 77 | 788 | 1.111e-14 | 9.381e-12 |
7 | INTRACELLULAR SIGNAL TRANSDUCTION | 119 | 1572 | 7.197e-14 | 4.784e-11 |
8 | TISSUE DEVELOPMENT | 114 | 1518 | 4.517e-13 | 2.627e-10 |
9 | RESPONSE TO ENDOGENOUS STIMULUS | 110 | 1450 | 6.536e-13 | 3.236e-10 |
10 | REGULATION OF CELL DEVELOPMENT | 76 | 836 | 6.954e-13 | 3.236e-10 |
11 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 72 | 771 | 8.088e-13 | 3.421e-10 |
12 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 129 | 1848 | 1.952e-12 | 7.567e-10 |
13 | POSITIVE REGULATION OF GENE EXPRESSION | 123 | 1733 | 2.324e-12 | 8.317e-10 |
14 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 84 | 1008 | 4.223e-12 | 1.404e-09 |
15 | MUSCLE STRUCTURE DEVELOPMENT | 49 | 432 | 4.979e-12 | 1.545e-09 |
16 | NEURON DIFFERENTIATION | 76 | 874 | 6.307e-12 | 1.834e-09 |
17 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 117 | 1656 | 1.192e-11 | 3.262e-09 |
18 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 115 | 1618 | 1.266e-11 | 3.274e-09 |
19 | REGULATION OF NEURON DIFFERENTIATION | 56 | 554 | 1.534e-11 | 3.756e-09 |
20 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 67 | 750 | 3.817e-11 | 8.878e-09 |
21 | PROTEIN PHOSPHORYLATION | 78 | 944 | 4.007e-11 | 8.878e-09 |
22 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 95 | 1275 | 8.197e-11 | 1.734e-08 |
23 | VASCULATURE DEVELOPMENT | 49 | 469 | 9.495e-11 | 1.921e-08 |
24 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 120 | 1784 | 1.451e-10 | 2.813e-08 |
25 | REGULATION OF PROTEIN MODIFICATION PROCESS | 116 | 1710 | 1.87e-10 | 3.481e-08 |
26 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 68 | 799 | 2.239e-10 | 4.004e-08 |
27 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 51 | 513 | 2.323e-10 | 4.004e-08 |
28 | RESPONSE TO MECHANICAL STIMULUS | 30 | 210 | 3.032e-10 | 5.039e-08 |
29 | NEURON DEVELOPMENT | 61 | 687 | 3.835e-10 | 6.153e-08 |
30 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 61 | 689 | 4.301e-10 | 6.672e-08 |
31 | REGULATION OF SYSTEM PROCESS | 50 | 507 | 4.635e-10 | 6.958e-08 |
32 | BIOLOGICAL ADHESION | 80 | 1032 | 4.791e-10 | 6.966e-08 |
33 | HEART DEVELOPMENT | 47 | 466 | 7.497e-10 | 1.057e-07 |
34 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 98 | 1395 | 9.766e-10 | 1.336e-07 |
35 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 43 | 408 | 1.05e-09 | 1.396e-07 |
36 | REGULATION OF CELL PROJECTION ORGANIZATION | 52 | 558 | 1.527e-09 | 1.973e-07 |
37 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 77 | 1004 | 1.692e-09 | 2.127e-07 |
38 | SINGLE ORGANISM BEHAVIOR | 41 | 384 | 1.758e-09 | 2.153e-07 |
39 | RESPONSE TO EXTERNAL STIMULUS | 118 | 1821 | 2.013e-09 | 2.402e-07 |
40 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 117 | 1805 | 2.346e-09 | 2.729e-07 |
41 | POSITIVE REGULATION OF LOCOMOTION | 43 | 420 | 2.553e-09 | 2.897e-07 |
42 | NEGATIVE REGULATION OF PHOSPHORYLATION | 43 | 422 | 2.949e-09 | 3.259e-07 |
43 | PHOSPHORYLATION | 88 | 1228 | 3.012e-09 | 3.259e-07 |
44 | MUSCLE TISSUE DEVELOPMENT | 33 | 275 | 3.864e-09 | 4.087e-07 |
45 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 50 | 541 | 4.194e-09 | 4.242e-07 |
46 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 50 | 541 | 4.194e-09 | 4.242e-07 |
47 | REGULATION OF CELL ADHESION | 55 | 629 | 5.012e-09 | 4.962e-07 |
48 | NEURON PROJECTION DEVELOPMENT | 50 | 545 | 5.354e-09 | 5.051e-07 |
49 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 95 | 1381 | 5.29e-09 | 5.051e-07 |
50 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 39 | 368 | 5.427e-09 | 5.051e-07 |
51 | NEURON PROJECTION MORPHOGENESIS | 41 | 402 | 6.728e-09 | 6.139e-07 |
52 | LOCOMOTION | 81 | 1114 | 7.139e-09 | 6.268e-07 |
53 | BEHAVIOR | 48 | 516 | 7.017e-09 | 6.268e-07 |
54 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 76 | 1021 | 8.001e-09 | 6.894e-07 |
55 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 121 | 1929 | 8.245e-09 | 6.976e-07 |
56 | RESPONSE TO ABIOTIC STIMULUS | 76 | 1024 | 9.074e-09 | 7.54e-07 |
57 | SKELETAL SYSTEM DEVELOPMENT | 44 | 455 | 9.517e-09 | 7.769e-07 |
58 | POSITIVE REGULATION OF CELL DEVELOPMENT | 45 | 472 | 9.954e-09 | 7.986e-07 |
59 | RESPONSE TO GROWTH FACTOR | 45 | 475 | 1.207e-08 | 9.519e-07 |
60 | CELLULAR COMPONENT MORPHOGENESIS | 69 | 900 | 1.282e-08 | 9.945e-07 |
61 | NEGATIVE REGULATION OF CELL COMMUNICATION | 84 | 1192 | 1.536e-08 | 1.172e-06 |
62 | EPITHELIUM DEVELOPMENT | 71 | 945 | 1.773e-08 | 1.302e-06 |
63 | CELLULAR RESPONSE TO OXYGEN LEVELS | 22 | 143 | 1.796e-08 | 1.302e-06 |
64 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 122 | 1977 | 1.818e-08 | 1.302e-06 |
65 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 73 | 983 | 1.78e-08 | 1.302e-06 |
66 | BONE DEVELOPMENT | 23 | 156 | 1.954e-08 | 1.378e-06 |
67 | COGNITION | 30 | 251 | 2.162e-08 | 1.502e-06 |
68 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 63 | 801 | 2.227e-08 | 1.502e-06 |
69 | MUSCLE CELL DIFFERENTIATION | 29 | 237 | 2.195e-08 | 1.502e-06 |
70 | REGULATION OF MEMBRANE POTENTIAL | 36 | 343 | 2.71e-08 | 1.801e-06 |
71 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 52 | 609 | 2.922e-08 | 1.915e-06 |
72 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 112 | 1791 | 3.874e-08 | 2.504e-06 |
73 | CELLULAR RESPONSE TO ACID CHEMICAL | 24 | 175 | 4.048e-08 | 2.545e-06 |
74 | BLOOD VESSEL MORPHOGENESIS | 37 | 364 | 4.028e-08 | 2.545e-06 |
75 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 33 | 303 | 4.252e-08 | 2.638e-06 |
76 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 80 | 1142 | 4.507e-08 | 2.76e-06 |
77 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 28 | 232 | 5.164e-08 | 3.12e-06 |
78 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 33 | 306 | 5.39e-08 | 3.215e-06 |
79 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 70 | 957 | 6.46e-08 | 3.805e-06 |
80 | ACTION POTENTIAL | 17 | 94 | 6.631e-08 | 3.857e-06 |
81 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 41 | 437 | 7.09e-08 | 4.023e-06 |
82 | CELL PROJECTION ORGANIZATION | 67 | 902 | 7.08e-08 | 4.023e-06 |
83 | RESPONSE TO OXYGEN LEVELS | 33 | 311 | 7.94e-08 | 4.451e-06 |
84 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 90 | 1360 | 8.455e-08 | 4.683e-06 |
85 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 33 | 312 | 8.569e-08 | 4.691e-06 |
86 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 65 | 872 | 9.868e-08 | 5.339e-06 |
87 | RESPONSE TO WOUNDING | 48 | 563 | 1.055e-07 | 5.602e-06 |
88 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 51 | 616 | 1.059e-07 | 5.602e-06 |
89 | POSITIVE REGULATION OF CELL COMMUNICATION | 98 | 1532 | 1.08e-07 | 5.647e-06 |
90 | TELENCEPHALON DEVELOPMENT | 27 | 228 | 1.322e-07 | 6.833e-06 |
91 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 79 | 1152 | 1.338e-07 | 6.844e-06 |
92 | EXTRACELLULAR STRUCTURE ORGANIZATION | 32 | 304 | 1.5e-07 | 7.588e-06 |
93 | KIDNEY EPITHELIUM DEVELOPMENT | 19 | 125 | 2.034e-07 | 1.017e-05 |
94 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 95 | 1492 | 2.147e-07 | 1.063e-05 |
95 | FOREBRAIN DEVELOPMENT | 35 | 357 | 2.263e-07 | 1.108e-05 |
96 | RESPONSE TO HORMONE | 65 | 893 | 2.338e-07 | 1.121e-05 |
97 | REGULATION OF OSSIFICATION | 23 | 178 | 2.33e-07 | 1.121e-05 |
98 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 72 | 1036 | 3.034e-07 | 1.426e-05 |
99 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 72 | 1036 | 3.034e-07 | 1.426e-05 |
100 | POSITIVE REGULATION OF CELL DEATH | 49 | 605 | 3.649e-07 | 1.698e-05 |
101 | REGULATION OF MAPK CASCADE | 52 | 660 | 3.744e-07 | 1.713e-05 |
102 | REGULATION OF CELL MORPHOGENESIS | 46 | 552 | 3.755e-07 | 1.713e-05 |
103 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 26 | 229 | 5.148e-07 | 2.326e-05 |
104 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 63 | 876 | 5.479e-07 | 2.451e-05 |
105 | RESPONSE TO NITROGEN COMPOUND | 62 | 859 | 5.992e-07 | 2.655e-05 |
106 | MUSCLE ORGAN DEVELOPMENT | 29 | 277 | 6.404e-07 | 2.801e-05 |
107 | HEAD DEVELOPMENT | 54 | 709 | 6.441e-07 | 2.801e-05 |
108 | SYSTEM PROCESS | 107 | 1785 | 6.576e-07 | 2.815e-05 |
109 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 60 | 823 | 6.594e-07 | 2.815e-05 |
110 | MULTICELLULAR ORGANISMAL SIGNALING | 18 | 123 | 7.539e-07 | 3.189e-05 |
111 | CELLULAR RESPONSE TO HORMONE STIMULUS | 45 | 552 | 9.219e-07 | 3.865e-05 |
112 | CELL CELL ADHESION | 48 | 608 | 1.001e-06 | 4.16e-05 |
113 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 55 | 740 | 1.084e-06 | 4.466e-05 |
114 | REGULATION OF CHEMOTAXIS | 22 | 180 | 1.11e-06 | 4.531e-05 |
115 | MESONEPHROS DEVELOPMENT | 15 | 90 | 1.167e-06 | 4.72e-05 |
116 | REGULATION OF MUSCLE SYSTEM PROCESS | 23 | 195 | 1.193e-06 | 4.787e-05 |
117 | ORGAN MORPHOGENESIS | 60 | 841 | 1.339e-06 | 5.323e-05 |
118 | CELL PART MORPHOGENESIS | 49 | 633 | 1.357e-06 | 5.352e-05 |
119 | CELLULAR RESPONSE TO LIPID | 39 | 457 | 1.633e-06 | 6.297e-05 |
120 | IMMUNE SYSTEM DEVELOPMENT | 46 | 582 | 1.635e-06 | 6.297e-05 |
121 | REGULATION OF CATABOLIC PROCESS | 54 | 731 | 1.638e-06 | 6.297e-05 |
122 | CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 13 | 70 | 1.698e-06 | 6.475e-05 |
123 | CELL MOTILITY | 59 | 835 | 2.233e-06 | 8.378e-05 |
124 | LOCALIZATION OF CELL | 59 | 835 | 2.233e-06 | 8.378e-05 |
125 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 74 | 1135 | 2.279e-06 | 8.483e-05 |
126 | REGULATION OF BLOOD CIRCULATION | 29 | 295 | 2.314e-06 | 8.544e-05 |
127 | REGULATION OF ION TRANSPORT | 46 | 592 | 2.591e-06 | 9.492e-05 |
128 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 92 | 1517 | 2.747e-06 | 9.986e-05 |
129 | ACTIN FILAMENT BASED PROCESS | 38 | 450 | 2.85e-06 | 0.000102 |
130 | RHYTHMIC PROCESS | 29 | 298 | 2.832e-06 | 0.000102 |
131 | UROGENITAL SYSTEM DEVELOPMENT | 29 | 299 | 3.027e-06 | 0.0001075 |
132 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 41 | 505 | 3.117e-06 | 0.0001099 |
133 | REGULATION OF GTPASE ACTIVITY | 50 | 673 | 3.414e-06 | 0.0001194 |
134 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 71 | 1087 | 3.475e-06 | 0.0001206 |
135 | REGULATION OF CATION TRANSMEMBRANE TRANSPORT | 23 | 208 | 3.636e-06 | 0.0001253 |
136 | SKELETAL MUSCLE ORGAN DEVELOPMENT | 18 | 137 | 3.699e-06 | 0.0001266 |
137 | CONNECTIVE TISSUE DEVELOPMENT | 22 | 194 | 3.896e-06 | 0.0001323 |
138 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 31 | 337 | 4.202e-06 | 0.0001417 |
139 | NEGATIVE REGULATION OF CELL PROLIFERATION | 48 | 643 | 4.718e-06 | 0.0001579 |
140 | REGULATION OF CELL PROLIFERATION | 90 | 1496 | 4.929e-06 | 0.0001638 |
141 | REGULATION OF TRANSPORT | 104 | 1804 | 5.585e-06 | 0.0001843 |
142 | MUSCLE CELL DEVELOPMENT | 17 | 128 | 5.907e-06 | 0.0001936 |
143 | IMMUNE SYSTEM PROCESS | 112 | 1984 | 6.077e-06 | 0.0001977 |
144 | MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 14 | 6.276e-06 | 0.0002028 |
145 | CARDIAC MUSCLE CELL ACTION POTENTIAL | 9 | 37 | 6.691e-06 | 0.0002147 |
146 | BONE MORPHOGENESIS | 13 | 79 | 6.924e-06 | 0.0002207 |
147 | STRIATED MUSCLE CELL DIFFERENTIATION | 20 | 173 | 7.94e-06 | 0.0002496 |
148 | REGULATION OF CELL SUBSTRATE ADHESION | 20 | 173 | 7.94e-06 | 0.0002496 |
149 | NEGATIVE REGULATION OF GENE EXPRESSION | 89 | 1493 | 8.015e-06 | 0.0002503 |
150 | CEREBRAL CORTEX DEVELOPMENT | 15 | 105 | 8.427e-06 | 0.0002614 |
151 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 38 | 472 | 8.649e-06 | 0.0002665 |
152 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 21 | 190 | 9.604e-06 | 0.000294 |
153 | CARTILAGE DEVELOPMENT | 18 | 147 | 1.007e-05 | 0.0003063 |
154 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 31 | 352 | 1.015e-05 | 0.0003066 |
155 | POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 8 | 30 | 1.049e-05 | 0.0003148 |
156 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 19 | 162 | 1.081e-05 | 0.0003223 |
157 | SINGLE ORGANISM CELL ADHESION | 37 | 459 | 1.102e-05 | 0.0003267 |
158 | TUBE DEVELOPMENT | 42 | 552 | 1.176e-05 | 0.0003464 |
159 | DEVELOPMENTAL MATURATION | 21 | 193 | 1.224e-05 | 0.0003581 |
160 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 39 | 498 | 1.252e-05 | 0.000364 |
161 | REGULATION OF DEVELOPMENTAL GROWTH | 27 | 289 | 1.307e-05 | 0.0003779 |
162 | TAXIS | 37 | 464 | 1.401e-05 | 0.0004025 |
163 | MEMBRANE DEPOLARIZATION | 11 | 61 | 1.428e-05 | 0.0004078 |
164 | RESPONSE TO LIPID | 59 | 888 | 1.46e-05 | 0.0004141 |
165 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 89 | 1518 | 1.519e-05 | 0.0004263 |
166 | REGULATION OF METAL ION TRANSPORT | 29 | 325 | 1.521e-05 | 0.0004263 |
167 | LEUKOCYTE DIFFERENTIATION | 27 | 292 | 1.575e-05 | 0.0004389 |
168 | RESPONSE TO DRUG | 35 | 431 | 1.623e-05 | 0.0004495 |
169 | ANGIOGENESIS | 27 | 293 | 1.675e-05 | 0.0004611 |
170 | REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 8 | 32 | 1.763e-05 | 0.0004826 |
171 | REGULATION OF TRANSPORTER ACTIVITY | 21 | 198 | 1.81e-05 | 0.0004924 |
172 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 26 | 278 | 1.847e-05 | 0.0004996 |
173 | WOUND HEALING | 37 | 470 | 1.858e-05 | 0.0004997 |
174 | REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 20 | 184 | 1.989e-05 | 0.000532 |
175 | POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 27 | 296 | 2.009e-05 | 0.0005343 |
176 | HOMEOSTATIC PROCESS | 80 | 1337 | 2.098e-05 | 0.0005546 |
177 | CIRCULATORY SYSTEM PROCESS | 31 | 366 | 2.185e-05 | 0.0005745 |
178 | SENSORY ORGAN DEVELOPMENT | 38 | 493 | 2.296e-05 | 0.0006001 |
179 | REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 6 | 17 | 2.348e-05 | 0.0006104 |
180 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 50 | 724 | 2.462e-05 | 0.0006363 |
181 | NEPHRON DEVELOPMENT | 15 | 115 | 2.567e-05 | 0.0006598 |
182 | CELLULAR RESPONSE TO RETINOIC ACID | 11 | 65 | 2.669e-05 | 0.0006824 |
183 | TRANSMISSION OF NERVE IMPULSE | 10 | 54 | 2.747e-05 | 0.0006984 |
184 | REGULATION OF HYDROLASE ACTIVITY | 79 | 1327 | 2.824e-05 | 0.0007141 |
185 | REGULATION OF CELLULAR COMPONENT SIZE | 29 | 337 | 2.986e-05 | 0.000747 |
186 | REGULATION OF CIRCADIAN RHYTHM | 14 | 103 | 2.971e-05 | 0.000747 |
187 | NEURON PROJECTION GUIDANCE | 21 | 205 | 3.053e-05 | 0.0007557 |
188 | REGULATION OF TRANSMEMBRANE TRANSPORT | 34 | 426 | 3.046e-05 | 0.0007557 |
189 | ENSHEATHMENT OF NEURONS | 13 | 91 | 3.33e-05 | 0.0008155 |
190 | AXON ENSHEATHMENT | 13 | 91 | 3.33e-05 | 0.0008155 |
191 | NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 20 | 191 | 3.422e-05 | 0.0008338 |
192 | CHEMICAL HOMEOSTASIS | 57 | 874 | 3.45e-05 | 0.0008362 |
193 | ENDOCHONDRAL BONE MORPHOGENESIS | 9 | 45 | 3.645e-05 | 0.0008756 |
194 | CELLULAR HOMEOSTASIS | 47 | 676 | 3.651e-05 | 0.0008756 |
195 | REGULATION OF KINASE ACTIVITY | 52 | 776 | 3.783e-05 | 0.0009028 |
196 | CELLULAR RESPONSE TO MECHANICAL STIMULUS | 12 | 80 | 4.057e-05 | 0.000963 |
197 | ORGAN GROWTH | 11 | 68 | 4.128e-05 | 0.0009728 |
198 | REGULATION OF CELL DEATH | 85 | 1472 | 4.14e-05 | 0.0009728 |
199 | ACTIN FILAMENT BASED MOVEMENT | 13 | 93 | 4.209e-05 | 0.0009842 |
200 | PROTEIN LOCALIZATION | 100 | 1805 | 4.329e-05 | 0.001007 |
201 | REGULATION OF CARDIAC MUSCLE CELL CONTRACTION | 7 | 27 | 4.629e-05 | 0.001072 |
202 | RESPONSE TO BMP | 13 | 94 | 4.72e-05 | 0.001082 |
203 | CELLULAR RESPONSE TO BMP STIMULUS | 13 | 94 | 4.72e-05 | 0.001082 |
204 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 58 | 905 | 4.804e-05 | 0.001096 |
205 | NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 34 | 437 | 5.084e-05 | 0.001154 |
206 | CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 18 | 166 | 5.268e-05 | 0.00119 |
207 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 24 | 262 | 5.342e-05 | 0.001201 |
208 | CIRCADIAN RHYTHM | 16 | 137 | 5.546e-05 | 0.001241 |
209 | T CELL DIFFERENTIATION | 15 | 123 | 5.695e-05 | 0.001268 |
210 | CELLULAR RESPONSE TO EXTERNAL STIMULUS | 24 | 264 | 6.027e-05 | 0.001335 |
211 | RESPONSE TO STEROID HORMONE | 37 | 497 | 6.111e-05 | 0.001341 |
212 | VASCULOGENESIS | 10 | 59 | 6.092e-05 | 0.001341 |
213 | PALLIUM DEVELOPMENT | 17 | 153 | 6.204e-05 | 0.001355 |
214 | REGULATION OF RESPONSE TO STRESS | 84 | 1468 | 6.323e-05 | 0.001375 |
215 | REGULATION OF GROWTH | 44 | 633 | 6.482e-05 | 0.001403 |
216 | RESPONSE TO ACID CHEMICAL | 27 | 319 | 7.374e-05 | 0.001571 |
217 | GLOMERULUS DEVELOPMENT | 9 | 49 | 7.393e-05 | 0.001571 |
218 | REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 9 | 49 | 7.393e-05 | 0.001571 |
219 | NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 13 | 98 | 7.341e-05 | 0.001571 |
220 | HEART PROCESS | 12 | 85 | 7.469e-05 | 0.00158 |
221 | CARDIAC MUSCLE CELL CONTRACTION | 7 | 29 | 7.622e-05 | 0.001605 |
222 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 26 | 303 | 7.956e-05 | 0.00166 |
223 | REGULATION OF HOMEOSTATIC PROCESS | 34 | 447 | 7.937e-05 | 0.00166 |
224 | MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 8 | 39 | 8.18e-05 | 0.001699 |
225 | REGULATION OF HEART RATE | 12 | 86 | 8.389e-05 | 0.001727 |
226 | REGULATION OF CELL SIZE | 18 | 172 | 8.384e-05 | 0.001727 |
227 | POSITIVE REGULATION OF CELL ADHESION | 30 | 376 | 8.846e-05 | 0.001813 |
228 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 58 | 926 | 8.999e-05 | 0.001836 |
229 | REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 6 | 21 | 9.056e-05 | 0.00184 |
230 | POSITIVE REGULATION OF MAPK CASCADE | 35 | 470 | 9.538e-05 | 0.00193 |
231 | STEM CELL DIFFERENTIATION | 19 | 190 | 9.938e-05 | 0.002002 |
232 | REGULATION OF MUSCLE ADAPTATION | 10 | 63 | 0.0001083 | 0.002172 |
233 | LEARNING | 15 | 131 | 0.0001176 | 0.002349 |
234 | POSITIVE REGULATION OF CELL PROLIFERATION | 52 | 814 | 0.0001281 | 0.002547 |
235 | MESONEPHRIC TUBULE MORPHOGENESIS | 9 | 53 | 0.0001395 | 0.002751 |
236 | CELLULAR RESPONSE TO AMINO ACID STIMULUS | 9 | 53 | 0.0001395 | 0.002751 |
237 | NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 8 | 42 | 0.0001421 | 0.002767 |
238 | REGULATION OF CELLULAR CARBOHYDRATE CATABOLIC PROCESS | 8 | 42 | 0.0001421 | 0.002767 |
239 | REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 8 | 42 | 0.0001421 | 0.002767 |
240 | METANEPHRIC NEPHRON DEVELOPMENT | 7 | 32 | 0.000149 | 0.00289 |
241 | REGULATION OF CYTOPLASMIC TRANSPORT | 35 | 481 | 0.0001497 | 0.00289 |
242 | CELLULAR RESPONSE TO ABIOTIC STIMULUS | 23 | 263 | 0.0001524 | 0.002931 |
243 | REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 6 | 23 | 0.000158 | 0.003016 |
244 | RESPONSE TO OXIDATIVE STRESS | 28 | 352 | 0.0001581 | 0.003016 |
245 | REGULATION OF VASOCONSTRICTION | 10 | 66 | 0.0001616 | 0.003032 |
246 | REGULATION OF CARDIAC MUSCLE CONTRACTION | 10 | 66 | 0.0001616 | 0.003032 |
247 | POSITIVE REGULATION OF CHEMOTAXIS | 14 | 120 | 0.000161 | 0.003032 |
248 | REGULATION OF DENDRITE DEVELOPMENT | 14 | 120 | 0.000161 | 0.003032 |
249 | MUSCLE SYSTEM PROCESS | 24 | 282 | 0.0001674 | 0.003128 |
250 | NEPHRON EPITHELIUM DEVELOPMENT | 12 | 93 | 0.0001801 | 0.003351 |
251 | NEGATIVE REGULATION OF KINASE ACTIVITY | 22 | 250 | 0.0001925 | 0.003555 |
252 | REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 14 | 122 | 0.000192 | 0.003555 |
253 | REGULATION OF AXONOGENESIS | 17 | 168 | 0.0001969 | 0.003621 |
254 | OSSIFICATION | 22 | 251 | 0.0002038 | 0.003733 |
255 | REGULATION OF ION HOMEOSTASIS | 19 | 201 | 0.000208 | 0.003766 |
256 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 34 | 470 | 0.0002066 | 0.003766 |
257 | SKELETAL SYSTEM MORPHOGENESIS | 19 | 201 | 0.000208 | 0.003766 |
258 | METANEPHROS DEVELOPMENT | 11 | 81 | 0.0002101 | 0.003773 |
259 | SPHINGOLIPID METABOLIC PROCESS | 15 | 138 | 0.0002108 | 0.003773 |
260 | POSITIVE REGULATION OF CATABOLIC PROCESS | 30 | 395 | 0.0002105 | 0.003773 |
261 | CELL ACTIVATION | 39 | 568 | 0.0002142 | 0.003803 |
262 | RESPONSE TO ESTROGEN | 20 | 218 | 0.000214 | 0.003803 |
263 | THYMOCYTE AGGREGATION | 8 | 45 | 0.0002351 | 0.004119 |
264 | GLYCOSPHINGOLIPID METABOLIC PROCESS | 10 | 69 | 0.0002355 | 0.004119 |
265 | T CELL DIFFERENTIATION IN THYMUS | 8 | 45 | 0.0002351 | 0.004119 |
266 | CARDIAC CONDUCTION | 11 | 82 | 0.0002346 | 0.004119 |
267 | NEURON MIGRATION | 13 | 110 | 0.0002402 | 0.004186 |
268 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 15 | 140 | 0.0002471 | 0.004289 |
269 | REGULATION OF HEART CONTRACTION | 20 | 221 | 0.0002565 | 0.004432 |
270 | MEMBRANE ASSEMBLY | 6 | 25 | 0.00026 | 0.004432 |
271 | EPITHELIAL CELL APOPTOTIC PROCESS | 6 | 25 | 0.00026 | 0.004432 |
272 | RESPONSE TO CYTOKINE | 46 | 714 | 0.0002579 | 0.004432 |
273 | EPITHELIAL CELL DIFFERENTIATION | 35 | 495 | 0.0002583 | 0.004432 |
274 | REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 70 | 0.0002657 | 0.004511 |
275 | NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 14 | 126 | 0.0002698 | 0.004565 |
276 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 13 | 112 | 0.0002875 | 0.004847 |
277 | NEGATIVE REGULATION OF CELL ADHESION | 20 | 223 | 0.0002889 | 0.004852 |
278 | PROTEIN DEPHOSPHORYLATION | 18 | 190 | 0.0002944 | 0.004928 |
279 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 30 | 404 | 0.0003091 | 0.005155 |
280 | RAS PROTEIN SIGNAL TRANSDUCTION | 15 | 143 | 0.0003115 | 0.005176 |
281 | REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 7 | 36 | 0.0003245 | 0.005374 |
282 | ENTRAINMENT OF CIRCADIAN CLOCK | 6 | 26 | 0.0003274 | 0.005403 |
283 | CARDIAC CHAMBER DEVELOPMENT | 15 | 144 | 0.0003359 | 0.005523 |
284 | LYMPHOCYTE DIFFERENTIATION | 19 | 209 | 0.0003423 | 0.005607 |
285 | CELL JUNCTION ASSEMBLY | 14 | 129 | 0.0003445 | 0.005625 |
286 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 40 | 602 | 0.0003484 | 0.005668 |
287 | REPRODUCTIVE SYSTEM DEVELOPMENT | 30 | 408 | 0.0003648 | 0.005914 |
288 | POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 9 | 60 | 0.0003686 | 0.005956 |
289 | REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 7 | 37 | 0.0003875 | 0.006238 |
290 | NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 15 | 146 | 0.0003898 | 0.006254 |
291 | CELL MATURATION | 14 | 131 | 0.0004037 | 0.006455 |
292 | REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 13 | 116 | 0.0004061 | 0.006472 |
293 | CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 6 | 27 | 0.0004078 | 0.006475 |
294 | REGULATION OF MUSCLE CONTRACTION | 15 | 147 | 0.0004194 | 0.006635 |
295 | ACTIN MEDIATED CELL CONTRACTION | 10 | 74 | 0.0004207 | 0.006635 |
296 | NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 12 | 102 | 0.00043 | 0.006737 |
297 | RENAL SYSTEM PROCESS | 12 | 102 | 0.00043 | 0.006737 |
298 | RESPIRATORY SYSTEM DEVELOPMENT | 18 | 197 | 0.0004566 | 0.00713 |
299 | REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 38 | 0.0004598 | 0.007155 |
300 | NEGATIVE REGULATION OF CELL CYCLE | 31 | 433 | 0.0004622 | 0.007169 |
301 | LEUKOCYTE ACTIVATION | 30 | 414 | 0.000465 | 0.007188 |
302 | TISSUE MORPHOGENESIS | 36 | 533 | 0.0005022 | 0.007719 |
303 | MUSCLE HYPERTROPHY | 6 | 28 | 0.0005027 | 0.007719 |
304 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 37 | 554 | 0.0005211 | 0.00785 |
305 | NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 4 | 11 | 0.0005216 | 0.00785 |
306 | NEGATIVE REGULATION OF GLYCOLYTIC PROCESS | 4 | 11 | 0.0005216 | 0.00785 |
307 | POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 4 | 11 | 0.0005216 | 0.00785 |
308 | NEGATIVE REGULATION OF COENZYME METABOLIC PROCESS | 4 | 11 | 0.0005216 | 0.00785 |
309 | TUBE MORPHOGENESIS | 25 | 323 | 0.000523 | 0.00785 |
310 | NEGATIVE REGULATION OF COFACTOR METABOLIC PROCESS | 4 | 11 | 0.0005216 | 0.00785 |
311 | CALCIUM MEDIATED SIGNALING | 11 | 90 | 0.000532 | 0.007959 |
312 | ADULT BEHAVIOR | 14 | 135 | 0.0005483 | 0.008099 |
313 | KIDNEY VASCULATURE DEVELOPMENT | 5 | 19 | 0.0005455 | 0.008099 |
314 | REGULATION OF CELL CELL ADHESION | 28 | 380 | 0.0005469 | 0.008099 |
315 | RENAL SYSTEM VASCULATURE DEVELOPMENT | 5 | 19 | 0.0005455 | 0.008099 |
316 | ION HOMEOSTASIS | 38 | 576 | 0.0005561 | 0.008188 |
317 | POSITIVE REGULATION OF ION TRANSPORT | 20 | 236 | 0.0005995 | 0.0088 |
318 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 13 | 121 | 0.0006107 | 0.008908 |
319 | CELL JUNCTION ORGANIZATION | 17 | 185 | 0.0006093 | 0.008908 |
320 | RESPONSE TO ISCHEMIA | 6 | 29 | 0.0006139 | 0.008927 |
321 | EMBRYONIC MORPHOGENESIS | 36 | 539 | 0.0006163 | 0.008933 |
322 | APPENDAGE DEVELOPMENT | 16 | 169 | 0.0006306 | 0.009084 |
323 | LIMB DEVELOPMENT | 16 | 169 | 0.0006306 | 0.009084 |
324 | REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 11 | 92 | 0.0006425 | 0.009199 |
325 | REGULATION OF INTRACELLULAR TRANSPORT | 40 | 621 | 0.000642 | 0.009199 |
326 | PLASMA MEMBRANE ORGANIZATION | 18 | 203 | 0.0006522 | 0.009309 |
327 | RESPONSE TO PEPTIDE | 29 | 404 | 0.0006674 | 0.009467 |
328 | EMBRYO DEVELOPMENT | 53 | 894 | 0.0006665 | 0.009467 |
329 | CELLULAR RESPONSE TO PEPTIDE | 22 | 274 | 0.0006811 | 0.009632 |
330 | RESPONSE TO MUSCLE ACTIVITY | 5 | 20 | 0.0007051 | 0.009941 |
331 | DENDRITE DEVELOPMENT | 10 | 79 | 0.0007135 | 0.009999 |
332 | REGULATION OF STRIATED MUSCLE CONTRACTION | 10 | 79 | 0.0007135 | 0.009999 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | ENZYME BINDING | 119 | 1737 | 5.574e-11 | 5.178e-08 |
2 | KINASE ACTIVITY | 67 | 842 | 4.875e-09 | 1.525e-06 |
3 | MACROMOLECULAR COMPLEX BINDING | 96 | 1399 | 4.926e-09 | 1.525e-06 |
4 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 36 | 328 | 8.43e-09 | 1.958e-06 |
5 | PROTEIN KINASE ACTIVITY | 54 | 640 | 2.348e-08 | 4.363e-06 |
6 | CYTOSKELETAL PROTEIN BINDING | 63 | 819 | 5.054e-08 | 7.47e-06 |
7 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 72 | 992 | 5.629e-08 | 7.47e-06 |
8 | PROTEIN COMPLEX BINDING | 68 | 935 | 1.25e-07 | 1.452e-05 |
9 | IDENTICAL PROTEIN BINDING | 81 | 1209 | 2.417e-07 | 2.495e-05 |
10 | KINASE BINDING | 49 | 606 | 3.832e-07 | 3.362e-05 |
11 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 26 | 226 | 3.981e-07 | 3.362e-05 |
12 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 50 | 629 | 4.845e-07 | 3.751e-05 |
13 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 31 | 315 | 1.019e-06 | 7.284e-05 |
14 | ACTIN BINDING | 35 | 393 | 2.143e-06 | 0.0001422 |
15 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 77 | 1199 | 2.466e-06 | 0.0001527 |
16 | PROTEIN DIMERIZATION ACTIVITY | 74 | 1149 | 3.545e-06 | 0.0002058 |
17 | PROTEIN DOMAIN SPECIFIC BINDING | 47 | 624 | 4.676e-06 | 0.0002555 |
18 | RECEPTOR BINDING | 89 | 1476 | 5.111e-06 | 0.0002638 |
19 | BINDING BRIDGING | 20 | 173 | 7.94e-06 | 0.0003882 |
20 | MOLECULAR FUNCTION REGULATOR | 82 | 1353 | 1.031e-05 | 0.0004791 |
21 | RIBONUCLEOTIDE BINDING | 104 | 1860 | 2.046e-05 | 0.0009053 |
22 | GLYCOPROTEIN BINDING | 14 | 101 | 2.373e-05 | 0.001002 |
23 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 35 | 445 | 3.167e-05 | 0.001279 |
24 | REGULATORY REGION NUCLEIC ACID BINDING | 54 | 818 | 4.02e-05 | 0.001556 |
25 | PROTEIN HOMODIMERIZATION ACTIVITY | 49 | 722 | 4.611e-05 | 0.001714 |
26 | VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 6 | 20 | 6.679e-05 | 0.002387 |
27 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 15 | 133 | 0.0001396 | 0.004641 |
28 | CALMODULIN BINDING | 18 | 179 | 0.0001399 | 0.004641 |
29 | CALCIUM ION BINDING | 46 | 697 | 0.00015 | 0.004805 |
30 | TUBULIN BINDING | 23 | 273 | 0.0002629 | 0.007879 |
31 | RECEPTOR SIGNALING PROTEIN ACTIVITY | 17 | 172 | 0.0002609 | 0.007879 |
32 | SEQUENCE SPECIFIC DNA BINDING | 61 | 1037 | 0.0003259 | 0.009461 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | NEURON PART | 97 | 1265 | 1.005e-11 | 2.934e-09 |
2 | MEMBRANE REGION | 90 | 1134 | 9.816e-12 | 2.934e-09 |
3 | CELL JUNCTION | 88 | 1151 | 1.201e-10 | 1.753e-08 |
4 | NEURON PROJECTION | 77 | 942 | 9.013e-11 | 1.753e-08 |
5 | CELL PROJECTION | 120 | 1786 | 1.556e-10 | 1.817e-08 |
6 | MEMBRANE MICRODOMAIN | 35 | 288 | 9.258e-10 | 9.011e-08 |
7 | ACTIN CYTOSKELETON | 45 | 444 | 1.489e-09 | 1.242e-07 |
8 | SYNAPSE | 62 | 754 | 5.51e-09 | 4.022e-07 |
9 | INTRINSIC COMPONENT OF PLASMA MEMBRANE | 104 | 1649 | 8.443e-08 | 5.478e-06 |
10 | SOMATODENDRITIC COMPARTMENT | 53 | 650 | 9.704e-08 | 5.667e-06 |
11 | CYTOSKELETON | 118 | 1967 | 1.508e-07 | 8.008e-06 |
12 | ANCHORING JUNCTION | 43 | 489 | 2.111e-07 | 1.027e-05 |
13 | POSTSYNAPSE | 36 | 378 | 3.102e-07 | 1.394e-05 |
14 | CELL SUBSTRATE JUNCTION | 36 | 398 | 1.067e-06 | 4.452e-05 |
15 | DENDRITE | 39 | 451 | 1.179e-06 | 4.591e-05 |
16 | MAIN AXON | 12 | 58 | 1.276e-06 | 4.656e-05 |
17 | CELL PROJECTION PART | 65 | 946 | 1.739e-06 | 5.974e-05 |
18 | PLASMA MEMBRANE REGION | 64 | 929 | 1.921e-06 | 6.232e-05 |
19 | BASAL PLASMA MEMBRANE | 9 | 33 | 2.373e-06 | 7.293e-05 |
20 | SYNAPSE PART | 47 | 610 | 2.538e-06 | 7.41e-05 |
21 | SARCOLEMMA | 17 | 125 | 4.261e-06 | 0.0001185 |
22 | SIDE OF MEMBRANE | 36 | 428 | 5.668e-06 | 0.0001505 |
23 | AXON | 35 | 418 | 8.417e-06 | 0.0002048 |
24 | CELL CELL JUNCTION | 33 | 383 | 8.389e-06 | 0.0002048 |
25 | PLASMA MEMBRANE PROTEIN COMPLEX | 40 | 510 | 9.365e-06 | 0.0002188 |
26 | INTRACELLULAR VESICLE | 77 | 1259 | 1.429e-05 | 0.0003209 |
27 | VACUOLE | 73 | 1180 | 1.652e-05 | 0.0003445 |
28 | BASAL PART OF CELL | 10 | 51 | 1.623e-05 | 0.0003445 |
29 | PLASMA MEMBRANE RAFT | 13 | 86 | 1.795e-05 | 0.0003615 |
30 | CELL LEADING EDGE | 30 | 350 | 2.359e-05 | 0.0004591 |
31 | T TUBULE | 9 | 45 | 3.645e-05 | 0.0006867 |
32 | I BAND | 15 | 121 | 4.699e-05 | 0.0008316 |
33 | CONTRACTILE FIBER | 21 | 211 | 4.679e-05 | 0.0008316 |
34 | CATION CHANNEL COMPLEX | 18 | 167 | 5.702e-05 | 0.0009794 |
35 | EXTRACELLULAR MATRIX COMPONENT | 15 | 125 | 6.87e-05 | 0.001146 |
36 | VOLTAGE GATED SODIUM CHANNEL COMPLEX | 5 | 14 | 0.0001098 | 0.001781 |
37 | CELL BODY | 36 | 494 | 0.0001174 | 0.001854 |
38 | ENDOPLASMIC RETICULUM | 90 | 1631 | 0.0001246 | 0.001915 |
39 | PROTEIN KINASE COMPLEX | 12 | 90 | 0.0001311 | 0.001963 |
40 | APICAL DENDRITE | 5 | 15 | 0.0001596 | 0.00233 |
41 | COATED PIT | 10 | 67 | 0.0001837 | 0.002495 |
42 | PERINUCLEAR REGION OF CYTOPLASM | 43 | 642 | 0.0001781 | 0.002495 |
43 | BASEMENT MEMBRANE | 12 | 93 | 0.0001801 | 0.002495 |
44 | LYTIC VACUOLE | 37 | 526 | 0.0001927 | 0.002558 |
45 | CYTOPLASMIC SIDE OF MEMBRANE | 17 | 170 | 0.0002269 | 0.002767 |
46 | A BAND | 7 | 34 | 0.0002232 | 0.002767 |
47 | EXTRINSIC COMPONENT OF MEMBRANE | 22 | 252 | 0.0002156 | 0.002767 |
48 | AXON PART | 20 | 219 | 0.0002274 | 0.002767 |
49 | CELL SURFACE | 48 | 757 | 0.0002742 | 0.003268 |
50 | CORTICAL ACTIN CYTOSKELETON | 9 | 58 | 0.0002838 | 0.003315 |
51 | SODIUM CHANNEL COMPLEX | 5 | 17 | 0.0003089 | 0.003538 |
52 | TRANSCRIPTIONAL REPRESSOR COMPLEX | 10 | 74 | 0.0004207 | 0.004724 |
53 | PROTEINACEOUS EXTRACELLULAR MATRIX | 27 | 356 | 0.0004378 | 0.004824 |
54 | EXCITATORY SYNAPSE | 18 | 197 | 0.0004566 | 0.004938 |
55 | SITE OF POLARIZED GROWTH | 15 | 149 | 0.0004845 | 0.005144 |
56 | CYTOSKELETAL PART | 78 | 1436 | 0.0005751 | 0.005997 |
57 | CELL CELL CONTACT ZONE | 9 | 64 | 0.0006013 | 0.006045 |
58 | NEURON SPINE | 13 | 121 | 0.0006107 | 0.006045 |
59 | MYELIN SHEATH | 16 | 168 | 0.0005909 | 0.006045 |
60 | LAMELLIPODIUM | 16 | 172 | 0.0007636 | 0.00731 |
61 | ENDOSOME | 48 | 793 | 0.0007625 | 0.00731 |
62 | CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 6 | 31 | 0.0008929 | 0.00841 |
63 | TRANSPORTER COMPLEX | 24 | 321 | 0.001084 | 0.009985 |
64 | EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 11 | 98 | 0.001094 | 0.009985 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04510_Focal_adhesion | 21 | 200 | 2.107e-05 | 0.0009998 | |
2 | hsa04380_Osteoclast_differentiation | 16 | 128 | 2.39e-05 | 0.0009998 | |
3 | hsa04151_PI3K_AKT_signaling_pathway | 30 | 351 | 2.489e-05 | 0.0009998 | |
4 | hsa04210_Apoptosis | 13 | 89 | 2.616e-05 | 0.0009998 | |
5 | hsa04010_MAPK_signaling_pathway | 25 | 268 | 2.777e-05 | 0.0009998 | |
6 | hsa04710_Circadian_rhythm_._mammal | 6 | 23 | 0.000158 | 0.004741 | |
7 | hsa04514_Cell_adhesion_molecules_.CAMs. | 14 | 136 | 0.0005906 | 0.01519 | |
8 | hsa04722_Neurotrophin_signaling_pathway | 13 | 127 | 0.000965 | 0.02096 | |
9 | hsa04115_p53_signaling_pathway | 9 | 69 | 0.001048 | 0.02096 | |
10 | hsa04390_Hippo_signaling_pathway | 14 | 154 | 0.001978 | 0.03439 | |
11 | hsa04630_Jak.STAT_signaling_pathway | 14 | 155 | 0.002102 | 0.03439 | |
12 | hsa04920_Adipocytokine_signaling_pathway | 8 | 68 | 0.003793 | 0.0569 | |
13 | hsa04660_T_cell_receptor_signaling_pathway | 10 | 108 | 0.007306 | 0.1006 | |
14 | hsa04014_Ras_signaling_pathway | 17 | 236 | 0.007824 | 0.1006 | |
15 | hsa04270_Vascular_smooth_muscle_contraction | 10 | 116 | 0.01182 | 0.1418 | |
16 | hsa04910_Insulin_signaling_pathway | 11 | 138 | 0.01477 | 0.1621 | |
17 | hsa04020_Calcium_signaling_pathway | 13 | 177 | 0.01603 | 0.1621 | |
18 | hsa04012_ErbB_signaling_pathway | 8 | 87 | 0.01621 | 0.1621 | |
19 | hsa04360_Axon_guidance | 10 | 130 | 0.02438 | 0.2309 | |
20 | hsa04310_Wnt_signaling_pathway | 11 | 151 | 0.02683 | 0.2415 | |
21 | hsa04912_GnRH_signaling_pathway | 8 | 101 | 0.03579 | 0.3068 | |
22 | hsa04144_Endocytosis | 13 | 203 | 0.04246 | 0.3285 | |
23 | hsa04150_mTOR_signaling_pathway | 5 | 52 | 0.04447 | 0.3285 | |
24 | hsa04914_Progesterone.mediated_oocyte_maturation | 7 | 87 | 0.04455 | 0.3285 | |
25 | hsa04720_Long.term_potentiation | 6 | 70 | 0.04694 | 0.3285 | |
26 | hsa00532_Glycosaminoglycan_biosynthesis_._chondroitin_sulfate | 3 | 22 | 0.04745 | 0.3285 | |
27 | hsa04540_Gap_junction | 7 | 90 | 0.05186 | 0.3457 | |
28 | hsa04971_Gastric_acid_secretion | 6 | 74 | 0.05866 | 0.3629 | |
29 | hsa04810_Regulation_of_actin_cytoskeleton | 13 | 214 | 0.05981 | 0.3629 | |
30 | hsa04662_B_cell_receptor_signaling_pathway | 6 | 75 | 0.06184 | 0.3629 | |
31 | hsa04530_Tight_junction | 9 | 133 | 0.0625 | 0.3629 | |
32 | hsa00052_Galactose_metabolism | 3 | 27 | 0.07867 | 0.4425 | |
33 | hsa04973_Carbohydrate_digestion_and_absorption | 4 | 44 | 0.08158 | 0.445 | |
34 | hsa04620_Toll.like_receptor_signaling_pathway | 7 | 102 | 0.08828 | 0.4674 | |
35 | hsa00340_Histidine_metabolism | 3 | 29 | 0.09312 | 0.4789 | |
36 | hsa04062_Chemokine_signaling_pathway | 11 | 189 | 0.09904 | 0.4952 | |
37 | hsa00604_Glycosphingolipid_biosynthesis_._ganglio_series | 2 | 15 | 0.1066 | 0.5188 | |
38 | hsa04672_Intestinal_immune_network_for_IgA_production | 4 | 49 | 0.1105 | 0.5232 | |
39 | hsa00770_Pantothenate_and_CoA_biosynthesis | 2 | 16 | 0.119 | 0.5466 | |
40 | hsa04730_Long.term_depression | 5 | 70 | 0.1215 | 0.5466 | |
41 | hsa04614_Renin.angiotensin_system | 2 | 17 | 0.1316 | 0.5779 | |
42 | hsa04114_Oocyte_meiosis | 7 | 114 | 0.1361 | 0.5781 | |
43 | hsa04520_Adherens_junction | 5 | 73 | 0.1381 | 0.5781 | |
44 | hsa00500_Starch_and_sucrose_metabolism | 4 | 54 | 0.1432 | 0.5835 | |
45 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 6 | 95 | 0.1459 | 0.5835 | |
46 | hsa00051_Fructose_and_mannose_metabolism | 3 | 36 | 0.151 | 0.5908 | |
47 | hsa00531_Glycosaminoglycan_degradation | 2 | 19 | 0.1578 | 0.6042 | |
48 | hsa04142_Lysosome | 7 | 121 | 0.1687 | 0.6328 | |
49 | hsa04916_Melanogenesis | 6 | 101 | 0.1779 | 0.6405 | |
50 | hsa04972_Pancreatic_secretion | 6 | 101 | 0.1779 | 0.6405 | |
51 | hsa00600_Sphingolipid_metabolism | 3 | 40 | 0.188 | 0.6637 | |
52 | hsa00410_beta.Alanine_metabolism | 2 | 22 | 0.1985 | 0.6871 | |
53 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 3 | 42 | 0.2074 | 0.698 | |
54 | hsa04350_TGF.beta_signaling_pathway | 5 | 85 | 0.2133 | 0.698 | |
55 | hsa04512_ECM.receptor_interaction | 5 | 85 | 0.2133 | 0.698 | |
56 | hsa00010_Glycolysis_._Gluconeogenesis | 4 | 65 | 0.2259 | 0.7049 | |
57 | hsa00310_Lysine_degradation | 3 | 44 | 0.2271 | 0.7049 | |
58 | hsa04962_Vasopressin.regulated_water_reabsorption | 3 | 44 | 0.2271 | 0.7049 | |
59 | hsa04970_Salivary_secretion | 5 | 89 | 0.2408 | 0.7346 | |
60 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 7 | 136 | 0.2485 | 0.7454 | |
61 | hsa00520_Amino_sugar_and_nucleotide_sugar_metabolism | 3 | 48 | 0.2676 | 0.7864 | |
62 | hsa04670_Leukocyte_transendothelial_migration | 6 | 117 | 0.2746 | 0.7864 | |
63 | hsa04976_Bile_secretion | 4 | 71 | 0.2753 | 0.7864 | |
64 | hsa00561_Glycerolipid_metabolism | 3 | 50 | 0.2881 | 0.8103 | |
65 | hsa04370_VEGF_signaling_pathway | 4 | 76 | 0.3176 | 0.8795 | |
66 | hsa04260_Cardiac_muscle_contraction | 4 | 77 | 0.3261 | 0.8894 | |
67 | hsa00040_Pentose_and_glucuronate_interconversions | 2 | 32 | 0.3382 | 0.9078 | |
68 | hsa04340_Hedgehog_signaling_pathway | 3 | 56 | 0.3501 | 0.9133 | |
69 | hsa04145_Phagosome | 7 | 156 | 0.3677 | 0.9456 | |
70 | hsa00565_Ether_lipid_metabolism | 2 | 36 | 0.3926 | 0.9952 | |
71 | hsa00230_Purine_metabolism | 7 | 162 | 0.4046 | 1 | |
72 | hsa04120_Ubiquitin_mediated_proteolysis | 6 | 139 | 0.4208 | 1 | |
73 | hsa00071_Fatty_acid_metabolism | 2 | 43 | 0.4824 | 1 | |
74 | hsa03320_PPAR_signaling_pathway | 3 | 70 | 0.4902 | 1 | |
75 | hsa02010_ABC_transporters | 2 | 44 | 0.4945 | 1 | |
76 | hsa04110_Cell_cycle | 5 | 128 | 0.5258 | 1 | |
77 | hsa04070_Phosphatidylinositol_signaling_system | 3 | 78 | 0.5634 | 1 | |
78 | hsa04612_Antigen_processing_and_presentation | 3 | 78 | 0.5634 | 1 | |
79 | hsa04664_Fc_epsilon_RI_signaling_pathway | 3 | 79 | 0.572 | 1 | |
80 | hsa00564_Glycerophospholipid_metabolism | 3 | 80 | 0.5806 | 1 | |
81 | hsa00983_Drug_metabolism_._other_enzymes | 2 | 52 | 0.5849 | 1 | |
82 | hsa04974_Protein_digestion_and_absorption | 3 | 81 | 0.5891 | 1 | |
83 | hsa04141_Protein_processing_in_endoplasmic_reticulum | 6 | 168 | 0.6045 | 1 | |
84 | hsa00140_Steroid_hormone_biosynthesis | 2 | 57 | 0.6351 | 1 | |
85 | hsa00562_Inositol_phosphate_metabolism | 2 | 57 | 0.6351 | 1 | |
86 | hsa04640_Hematopoietic_cell_lineage | 3 | 88 | 0.6452 | 1 | |
87 | hsa00590_Arachidonic_acid_metabolism | 2 | 59 | 0.6538 | 1 | |
88 | hsa00240_Pyrimidine_metabolism | 3 | 99 | 0.722 | 1 | |
89 | hsa03015_mRNA_surveillance_pathway | 2 | 83 | 0.8226 | 1 | |
90 | hsa04740_Olfactory_transduction | 2 | 388 | 1 | 1 |